In cancer cells, aberrant poly(ribosyl)ation activity or its controlling PARG activity disrupts DNA methylation; in some cases, it may be hyper- or hypomethylation depending on the cues that affect the poly(ribosyl)ation of DNMT1 [98]. The gene discussed is DNMT1; the disease is cancer.